Granahan Investment Management, LLC Biocryst Pharmaceuticals Inc Transaction History

Granahan Investment Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$7.89 - $17.88 $3.7 Million - $8.39 Million	-469,430 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$11.56 - $19.76 $7.64 Million - $13.1 Million	-661,148 Reduced 58.48%	469,430 $7.63 Million
Q4 2021 Feb 14, 2022	BUY	$11.18 - $15.46 $2.94 Million - $4.06 Million	262,658 Added 30.26%	1,130,578 $15.7 Million
Q3 2021 Nov 15, 2021	BUY	$14.21 - $17.65 $5.88 Million - $7.31 Million	413,925 Added 91.17%	867,920 $12.5 Million
Q2 2021 Aug 16, 2021	BUY	$9.5 - $17.24 $228,883 - $415,363	24,093 Added 5.6%	453,995 $7.18 Million
Q1 2021 May 17, 2021	BUY	$7.37 - $13.61 $3.17 Million - $5.85 Million	429,902 New	429,902 $4.37 Million

279

172M

625K

739K

Ticker BCRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,944,992
Market Cap $1.41B
Description
BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...

Get notified when there are updates to the investment portfolio of Granahan Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Granahan Investment Management, LLC with notifications on news.